VIDEO: Verséa offers amniotic membrane graft, point-of-care testing platform
Click Here to Manage Email Alerts
WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Rahim Hirji, RPh, describes the products available from Verséa Ophthalmics.
Hirji said Biovance 3L Ocular is a three-layer decellularized ringless human amniotic membrane graft that can be used for dry eye disease, superficial keratectomy, sub-Bowman’s keratomileusis or neurotrophic keratitis, as well as surgical procedures such as pterygium excision and tube shunt surgery.
The company also offers a tear-based point-of-care (T-POC) quantitative testing platform to test total immunoglobulin E to discern allergic vs. nonallergic etiology in patients with red eye or signs and symptoms of ocular surface disease, while T-POC lactoferrin helps to differentiate aqueous deficiency and evaporative dry eye disease.
“All of this can now be done at the point of care with a tear sample as small as 1 µL and results delivered in just 6 to 8 minutes,” Hirji said. “T-POC testing is rapid, repeatable, reproducible and also reimbursable.”
Collapse
Healio Interviews
Read more about
Click Here to Manage Email Alerts